Tetrous
Sherman Oaks, US · Founded 2019 · Delaware corporation
Find your way into Tetrous
Sign up to see every warm intro you have to Tetrous
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tetrous team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tetrous is a regenerative medicine company developing demineralized bone fiber (DBF) EnFix implants that support biologic healing at the bone-to-tendon junction (enthesis) following sports medicine surgery. Its products are used by orthopedic surgeons across procedures such as rotator cuff, Achilles, gluteus medius, biceps, and lateral epicondylar repairs.
Founders & leadership
Tetrous was founded in 2019 by Andrew J. Carter.

Board
Funding
SEC filings, press & company announcements$2.2M disclosed across 2 of 3 rounds · 2023–2026
- Undisclosed amountSeries AMar 2025Source ↗
▶$1.7MraisedApr 2026 · 64 investors · BiotechnologyRule 506(b)
- Gunnar AnderssonDirector
- Nikhil VermaDirector
- Matthew MuscioDirector
- Andy CarterDirector
- Frank PhilipsDirector
- John BojanowskiDirector
- Simon BerryDirector
- Jan IwanczykDirector
- Bradley E. PattExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.7M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$444.6KraisedDec 2023 · 2 investors · BiotechnologyRule 506(c)
- Nikhil VermaDirector
- Jan IwanczykDirector
- John BojanowskiDirector
- Frank PhillipsDirector
- Gunnar AnderssonDirector
- Bradley E. PattExecutive Officer, Director
- Andy CarterDirector
- Simon BerryDirector
- Offering amount
- $5M
- Amount sold
- $444.6K
- Minimum investment
- $50K
- Placement agents
- Sutter Securities Group
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Tetrous.
In the news
Frequently asked questions
- What does Tetrous do?
- Tetrous is a regenerative medicine company developing demineralized bone fiber (DBF) EnFix implants that support biologic healing at the bone-to-tendon junction (enthesis) following sports medicine surgery. Its products are used by orthopedic surgeons across procedures such as rotator cuff, Achilles, gluteus medius, biceps, and lateral epicondylar repairs.
- Who founded Tetrous?
- Tetrous was founded by Andrew J. Carter in 2019.
- How much funding has Tetrous raised?
- Tetrous has disclosed $2.2M raised across 2 of its 3 known rounds.
- Where is Tetrous headquartered?
- Tetrous is headquartered in Sherman Oaks, US.


